litlas
ログインアカウント作成

Per Svenningsson

1995–2026 年に発表

238
論文数
23,641
被引用数
88
h 指数
216
i10 指数

被引用数

Per Svenningsson の年別被引用数1983 年: 被引用 1 件1986 年: 被引用 1 件1991 年: 被引用 2 件1992 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 3 件1997 年: 被引用 17 件1998 年: 被引用 19 件1999 年: 被引用 50 件2000 年: 被引用 32 件2001 年: 被引用 82 件2002 年: 被引用 67 件2003 年: 被引用 128 件2004 年: 被引用 154 件2005 年: 被引用 146 件2006 年: 被引用 148 件2007 年: 被引用 189 件2008 年: 被引用 187 件2009 年: 被引用 175 件2010 年: 被引用 205 件2011 年: 被引用 289 件2012 年: 被引用 214 件2013 年: 被引用 187 件2014 年: 被引用 146 件2015 年: 被引用 183 件2016 年: 被引用 196 件2017 年: 被引用 180 件2018 年: 被引用 191 件2019 年: 被引用 642 件2020 年: 被引用 677 件2021 年: 被引用 774 件2022 年: 被引用 735 件2023 年: 被引用 603 件2024 年: 被引用 996 件2025 年: 被引用 631 件2026 年: 被引用 30 件1984〜1985 年は被引用が無いため表示していません1987〜1990 年は被引用が無いため表示していません1993〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,673 件、この内訳の 23.4%イギリス: 引用元論文 892 件、この内訳の 7.8%中国: 引用元論文 828 件、この内訳の 7.3%スウェーデン: 引用元論文 744 件、この内訳の 6.5%ドイツ: 引用元論文 630 件、この内訳の 5.5%イタリア: 引用元論文 630 件、この内訳の 5.5%フランス: 引用元論文 477 件、この内訳の 4.2%カナダ: 引用元論文 459 件、この内訳の 4%スペイン: 引用元論文 426 件、この内訳の 3.7%日本: 引用元論文 262 件、この内訳の 2.3%オランダ: 引用元論文 261 件、この内訳の 2.3%オーストラリア: 引用元論文 247 件、この内訳の 2.2%
0%23.4%その他 25.3%

機関

分野

  • Medicine41.3%
  • Neuroscience27.1%
  • Biochemistry, Genetics and Molecular Biology22%
  • Chemistry3%
  • Psychology1.5%
  • Immunology and Microbiology1%
  • その他4.1%

トピック

  • Parkinson's Disease Mechanisms and Treatments7.8%
  • Neuroscience and Neuropharmacology Research5.3%
  • Neurological disorders and treatments4.5%
  • Neurotransmitter Receptor Influence on Behavior4%
  • Alzheimer's disease research and treatments3.3%
  • Receptor Mechanisms and Signaling3.3%
  • その他71.8%

共著者

全論文

検索で開く
  1. A multicentre validation study of the diagnostic value of plasma neurofilament light

    著者: Nicholas J. Ashton, Shorena Janelidze, Ahmad Al Khleifat, Antoine Leuzy, Emma L. van der Ende, Thomas K. Karikari, Andréa Lessa Benedet, Tharick A. Pascoal, Alberto Lleó, Lucilla Parnetti, Daniela Galimberti, Laura Bonanni, Andrea Pilotto, Alessandro Padovani, Jan Lycke, Lenka Novakova, Markus Axelsson, Latha Velayudhan, Gil D. Rabinovici, Bruce L. Miller, Carmine M. Pariante, Naghmeh Nikkheslat, Susan M. Resnick, Madhav Thambisetty, Michael Schöll, Gorka Fernández‐Eulate, Francisco J. Gil‐Bea, Adolfo López de Munaín, Ammar Al‐Chalabi, Pedro Rosa‐Neto, André Strydom, Per Svenningsson, Erik Stomrud, Alexander Santillo, Dag Aarsland, John C. van Swieten, Sebastian Palmqvist, Henrik Zetterberg, Kaj Blennow, Abdul Hye, Oskar Hansson - Nature Communications 2021 被引用: 555

  2. Spatial multimodal analysis of transcriptomes and metabolomes in tissues

    著者: Marco Vicari, Reza Mirzazadeh, Anna Nilsson, Mohammadreza Shariatgorji, Patrik Bjärterot, Ludvig Larsson, Hower Lee, Mats Nilsson, Julia Foyer, Markus Ekvall, Paulo Czarnewski, Xiaoqun Zhang, Per Svenningsson, Lukas Käll, Per E. Andrén, Joakim Lundeberg - Nature Biotechnology 2023 被引用: 146

  3. The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases

    著者: Ruben Smith, Francesca Capotosti, Martin Schain, Tomas Ohlsson, Efthymia Vokali, Jérôme Molette, Tanja Touilloux, Valerie Hliva, Ioannis K. Dimitrakopoulos, Andreas Puschmann, Jonas Jögi, Per Svenningsson, Mattias Andréasson, Christine Sandiego, David Russell, Patrícia Miranda-Azpiazu, Christer Halldin, Erik Stomrud, Sara Hall, Klas Bratteby, Elina Tampio L’Estrade, Ruth Luthi‐Carter, Andrea Pfeifer, Marie Kosco‐Vilbois, Johannes Streffer, Oskar Hansson - Nature Communications 2023 被引用: 140

  4. Vagotomy and Parkinson disease

    著者: Bojing Liu, Fang Fang, Nancy L. Pedersen, Annika Tillander, Jonas F. Ludvigsson, Anders Ekbom, Per Svenningsson, Honglei Chen, Karin Wirdefeldt - Neurology 2017 被引用: 442

  5. A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease

    著者: Francisco Cardoso, Christopher G. Goetz, Tiago Mestre, Cristina Sampaio, Charles H. Adler, Daniela Berg, Bastiaan R. Bloem, David J. Burn, Michael S. Fitts, Thomas Gasser, Christine Klein, Marina A.J. Tijssen, Anthony E. Lang, Shen‐Yang Lim, Irene Litvan, Wassilios G. Meissner, Brit Mollenhauer, Njideka Okubadejo, Michael S. Okun, Ronald B. Postuma, Per Svenningsson, Louis C.S. Tan, Taiji Tsunemi, Sarah Wahlstrom‐Helgren, Oscar S. Gershanik, Victor S.C. Fung, Claudia Trenkwalder - Movement Disorders 2023 被引用: 82

  6. Depression in Parkinson disease—epidemiology, mechanisms and management

    著者: Dag Aarsland, Sven Påhlhagen, Clive Ballard, Uwe Ehrt, Per Svenningsson - Nature Reviews Neurology 2011 被引用: 586

  7. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment

    著者: Per Svenningsson, Eric Westman, Clive Ballard, Dag Aarsland - The Lancet Neurology 2012 被引用: 511

  8. Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export

    著者: Andrea Legati, Donatella Giovannini, Gaël Nicolas, Uriel López-Sánchez, Beatriz Quintáns, João Ricardo Mendes de Oliveira, Renee Sears, Eliana Marisa Ramos, Elizabeth Spiteri, María-Jesús Sobrido, Ángel Carracedo, Cristina Castro-Fernández, Stéphanie Cubizolle, Brent L. Fogel, Cyril Goizet, Joanna C. Jen, Suppachok Kirdlarp, Anthony E. Lang, Zosia Miedzybrodzka, Witoon Mitarnun, Martin Paucar, Henry L. Paulson, Jérémie Pariente, Anne-Claire Richard, Naomi Salins, Sheila A Simpson, Pasquale Striano, Per Svenningsson, François Tison, Vivek K. Unni, Olivier Vanakker, Marja W. Wessels, Suppachok Wetchaphanphesat, Michele Yang, François Boller, Dominique Campion, Didier Hannequin, Marc Sitbon, Daniel H. Geschwind, Jean‐Luc Battini, Giovanni Coppola - Nature Genetics 2015 被引用: 316

  9. The noradrenergic subtype of Parkinson disease: from animal models to clinical practice

    著者: К. Ray Chaudhuri, Valentina Leta, Kirsty Bannister, David J. Brooks, Per Svenningsson - Nature Reviews Neurology 2023 被引用: 78

  10. Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice

    著者: Annika Keller, Ana Westenberger, María Jesús Sobrido, María García-Murias, Aloysius Domingo, Renee Sears, Roberta R. Lemos, Andrés Ordóñez‐Ugalde, Gaël Nicolas, José Eriton Gomes da Cunha, Elisabeth J. Rushing, Michael Hugelshofer, Moritz C. Wurnig, Andres Kaech, Regina Reimann, Katja Lohmann, Valerija Dobričić, Ángel Carracedo, Igor Petrović, Janis M. Miyasaki, Irina Abakumova, Maarja Andaloussi Mäe, Elisabeth Raschperger, Mayana Zatz, Katja Zschiedrich, Jörg Klepper, Elizabeth Spiteri, José M. Prieto, Inmaculada Navas, Michael Preuß, Carmen Dering, Milena Janković, Martin Paucar, Per Svenningsson, Kioomars Saliminejad, Hamid Reza Khorram Khorshid, Ivana Novaković, Adriano Aguzzi, Andreas Boss, Isabelle Le Ber, Gilles Defer, Didier Hannequin, Vladimir S Kostić, Dominique Campion, Daniel H. Geschwind, Giovanni Coppola, Christer Betsholtz, Christine Klein, João Ricardo Mendes de Oliveira - Nature Genetics 2013 被引用: 328

  11. An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

    著者: Nicholas J. Ashton, Abdul Hye, Anto P. Rajkumar, Antoine Leuzy, Stuart G. Snowden, Marc Suárez‐Calvet, Thomas K. Karikari, Michael Schöll, Renaud La Joie, Gil D. Rabinovici, Kina Höglund, Clive Ballard, Tibor Hortobágyi, Per Svenningsson, Kaj Blennow, Henrik Zetterberg, Dag Aarsland - Nature Reviews Neurology 2020 被引用: 196

  12. Comprehensive mapping of neurotransmitter networks by MALDI–MS imaging

    著者: Mohammadreza Shariatgorji, Anna Nilsson, Elva Fridjonsdottir, Theodosia Vallianatou, Patrik Källback, Luay Katan, Jonas Sävmarker, Ioannis Mantas, Xiaoqun Zhang, Erwan Bézard, Per Svenningsson, Luke R. Odell, Per E. Andrén - Nature Methods 2019 被引用: 237

  13. Reduced incidence of Parkinson's disease after dipeptidyl peptidase‐4 inhibitors—A nationwide case‐control study

    著者: Per Svenningsson, Karin Wirdefeldt, Li Yin, Fang Fang, Ioanna Markaki, Suad Efendić, Jonas F. Ludvigsson - Movement Disorders 2016 被引用: 99

  14. Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson’s disease

    著者: Aurelija Jučaitė, Per Svenningsson, Juha O. Rinne, Zsolt Cselényi, Katarina Varnäs, Peter Johnström, Nahid Amini, Anna K. Kirjavainen, Semi Helin, Margaret Minkwitz, Alan R. Kugler, Joel A. Posener, Samantha L. Budd, Christer Halldin, Andrea Varrone, Lars Farde - Brain 2015 被引用: 222

  15. Genome-wide Association Analysis of Parkinson’s Disease and Schizophrenia Reveals Shared Genetic Architecture and Identifies Novel Risk Loci

    著者: Olav B. Smeland, Alexey Shadrin, Shahram Bahrami, Iris Broce, Martin Tesli, Oleksandr Frei, Katrine V. Wirgenes, Kevin S. O’Connell, Florian Krull, Francesco Bettella, Nils Eiel Steen, Leo P. Sugrue, Yunpeng Wang, Per Svenningsson, Manu Sharma, Lasse Pihlstrøm, Mathias Toft, Michael O‘Donovan, Srdjan Djurovic, Rahul S. Desikan, Anders M. Dale, Ole A. Andreassen - Biological Psychiatry 2020 被引用: 104

  16. Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents

    著者: Yachao He, Ibrahim Kaya, Mohammadreza Shariatgorji, Johan Lundkvist, Lars U. Wahlberg, Anna Nilsson, Dejan Mamula, Ján Kehr, Justyna Zarȩba-Pasławska, Henrik Biverstål, Karima Chergui, Xiaoqun Zhang, Per E. Andrén, Per Svenningsson - Nature Communications 2023 被引用: 59

  17. Fixation Duration and Pupil Size as Diagnostic Tools in Parkinson’s Disease

    著者: Panagiota Tsitsi, Mattias Nilsson, Gustaf Öqvist Seimyr, Olof Larsson, Per Svenningsson, Ioanna Markaki - Journal of Parkinson s Disease 2021 被引用: 59

  18. Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson’s disease primate model

    著者: Ibrahim Kaya, Anna Nilsson, Dominika Luptáková, Yachao He, Theodosia Vallianatou, Patrik Bjärterot, Per Svenningsson, Erwan Bézard, Per E. Andrén - npj Parkinson s Disease 2023 被引用: 47

  19. Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease

    著者: Wojciech Pasławski, Shervin Khosousi, Ellen Hertz, Ioanna Markaki, Adam L. Boxer, Per Svenningsson - Translational Neurodegeneration 2023 被引用: 46

  20. Adenosine and Brain Function

    著者: Bertil B. Fredholm, Jiang‐Fan Chen, Rodrigo A. Cunha, Per Svenningsson, Jean‐Marie Vaugeois - International review of neurobiology 2005 被引用: 689

  21. The role of 5-HT1A receptors in learning and memory

    著者: Sven Ove Ögren, Therése Eriksson, E. Elvander-Tottie, Claudio D’Addario, Joanna Ekström, Per Svenningsson, Björn Meister, Ján Kehr, Oliver Stiedl - Behavioural Brain Research 2008 被引用: 340

  22. Reduction of spontaneous cortical beta bursts in Parkinson’s disease is linked to symptom severity

    著者: Mikkel C. Vinding, Panagiota Tsitsi, Josefine Waldthaler, Robert Oostenveld, Martin Ingvar, Per Svenningsson, Daniel Lundqvist - Brain Communications 2020 被引用: 67

  23. Spatial visualization of comprehensive brain neurotransmitter systems and neuroactive substances by selective in situ chemical derivatization mass spectrometry imaging

    著者: Mohammadreza Shariatgorji, Anna Nilsson, Elva Fridjonsdottir, Nicole Strittmatter, Andreas Dannhorn, Per Svenningsson, Richard J. A. Goodwin, Luke R. Odell, Per E. Andrén - Nature Protocols 2021 被引用: 62

  24. AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine–associated receptor 1

    著者: Alejandro Díaz‐Holguín, Marcus Saarinen, Duc Duy Vo, Andrea Sturchio, Niclas Branzell, Israel Cabeza de Vaca, Huabin Hu, Núria Mitjavila-Domènech, Annika Lindqvist, Paweł Baranczewski, Mark J. Millan, Yunting Yang, Jens Carlsson, Per Svenningsson - Science Advances 2024 被引用: 51